Photodynamic therapy for photochemists

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 371, Issue 1995, 2013, Pages

  Bown, Stephen G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer therapy; Lasers; Minimally invasive treatment; Photodynamic therapy

Indexed keywords

CHEMOTHERAPY; COLLAGEN; LASERS; MUSCULOSKELETAL SYSTEM; OPHTHALMOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; RADIOTHERAPY; TISSUE;

AGE-RELATED MACULAR DEGENERATION; BALLOON ANGIOPLASTY; CANCER THERAPY; IMMUNOLOGICAL RESPONSE; MECHANICAL INTEGRITY; MINIMALLY INVASIVE TREATMENTS; PHOTODYNAMIC THERAPY (PDT); TEMPERATURE CHANGES;

DISEASES;

PHOTOSENSITIZING AGENT;

ANIMAL; CANCER THERAPY; HUMAN; LASER; MINIMALLY INVASIVE PROCEDURE; NEOPLASM; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; REVIEW; SYNTHESIS;

CANCER THERAPY; LASERS; MINIMALLY INVASIVE TREATMENT; PHOTODYNAMIC THERAPY;

ANIMALS; HUMANS; NEOPLASMS; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84887333490     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2012.0371     Document Type: Review

References (45)

1. Dolmans DE, Fukumura D, Jain RK. 2003 Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387. (doi:10.1038/nrc1071) (Pubitemid 37328858)
2. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. 1998 Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905. (doi:10.1093/jnci/90.12.889) (Pubitemid 28304157)
3. Hopper C. 2000 Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 1, 212-219. (doi:10.1016/S1470-2045(00)00166-2)
4. Grant WE, Speight PM, Hopper C, Bown SG. 1997 Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int. J. Cancer 71, 937-942. (doi:10.1002/(SICI)1097-0215(19970611)71:63. 0.CO;2-Z) (Pubitemid 27252871)
5. Bown SG. 1990 Photodynamic therapy to scientists and clinicians: one world or two J. Photochem. Photobiol. B 6, 1-12. (doi:10.1016/1011-1344(90) 85069-9)
6. Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Tilly R, Bown SG. 1987 The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem. Photobiol. 46, 795-800. (doi:10.1111/j.1751-1097. 1987.tb04850.x)
7. Grant WE, Speight PM, MacRobert AJ, Hopper C, Bown SG. 1994 Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer 70, 72-78. (doi:10.1038/bjc.1994.252) (Pubitemid 24203631)
8. Trushina OI, Novikova EG, Sokolov VV, Filonenko EV, Chissov VI, Vorozhtsov GN. 2008 Photodynamic therapy of virus-associated precancer and early stages cancer of cervix uteri. Photodiagnosis Photodyn. Ther. 5, 256-259. (doi:10.1016/j.pdpdt.2008.09.005)
9. Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Krasner N, Phillips D, Bown SG. 1990 Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology 98, 1532-1537. (Pubitemid 20158617)
10. Chevalier S, Anidjar M, Scarlata E, Hamel L, Scherz A, Ficheux H, Borenstein N, Fiette L, Elhilali M. 2011 Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. J. Urol. 186, 302-329. (doi:10.1016/j.juro.2011.03.039)
11. Hermann GG, Mogensen K, Carlsson S, Marcussen N, Duun S. 2011 Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int. 108, E297-E303. (doi:10.1111/j.1464-410X. 2011.10090.x)
12. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. 2005 Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J. Natl Cancer Inst. 97, 1516-1524. (doi:10.1093/jnci/dji314) (Pubitemid 41631951)
13. Li WT. 2009 Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancers. Curr. Drug Metab. 10, 851-860. (doi:10.2174/138920009790274559)
14. Bown SG et al. 2002 Photodynamic therapy for cancer of the pancreas. Gut 50, 549-557. (doi:10.1136/gut.50.4.549) (Pubitemid 34638877)
15. Trachtenberg J et al. 2008 Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int. 102, 556-562. (doi:10.1111/j.1464-410X.2008.07753.x)
16. Betrouni N, Lopes R, Puech P, Colin P, Mordon S. 2011 A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD soluble WST11. Phys. Med. Biol. 56, 4771-4783. (doi:10.1088/0031-9155/56/15/009)
17. Morton CA, McKenna KE, Rhodes LE. 2008 Guidelines for topical photodynamic therapy: update. Br. J. Dermatol. 159, 1245-1266. (doi:10.1111/j.1365-2133.2008.08882.x)
18. Ibbotson S. 2006 Photodynamic therapy. In Photodermatology (eds J Ferguson, J Dover), pp. 125-134. London, UK: Manson Publishing.
19. Perrett CM, McGregor JM, Warwick J, Karran P, Leigh IM, Proby CM, Harwood CA. 2007 Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br. J. Dermatol. 156, 320-328. (doi:10.1111/j.1365-2133.2006.07616.x) (Pubitemid 46095961)
20. Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C. 2004 Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br. J. Cancer 91, 441-446. (doi:10.1038/sj.bjc.6601993) (Pubitemid 39093561)
21. Biel MA. 2007 Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem. Photobiol. 83, 1063-1068. (doi:10.1111/j.1751-1097.2007. 00153.x) (Pubitemid 47438525)
22. Hopper C, Kubler A, Lewis H, Tan IB, Putnam G. 2004 mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int. J. Cancer 111, 138-146. (doi:10.1002/ijc.20209) (Pubitemid 38859295)
23. Kennedy TC et al. 2007 Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(Suppl. 3), 221S-233S. (doi:10.1378/chest.07-1377)
24. Overholt BF et al. 2007 Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest. Endosc. 66, 460-468. (doi:10.1016/j.gie.2006.12.037) (Pubitemid 47304412)
25. Moghissi K, Dixon K, Stringer M, Thorpe JA. 2009 Photofrin PDT for early stage oesophageal cancer: long term results in 40 patients and literature review. Photodiagnosis Photodyn. Ther. 6, 159-166. (doi:10.1016/j.pdpdt.2009.07. 026)
26. Matull WR et al. 2011 R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int. 31, 99-107. (doi:10.1111/j.1478-3231.2010.02345.x)
27. Kostron H. 2010 Photodynamic diagnosis and therapy and the brain. Methods Mol. Biol. 635, 261-280. (doi:10.1007/978-1-60761-697-9-17)
28. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. 2006 Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392-401. (doi:10.1016/S1470-2045(06)70665-9)
29. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. 2007 Will focal therapy become a standard of care for men with localized prostate cancer Nat. Clin. Pract. Oncol. 4, 632-642. (doi:10.1038/ncponc0959) (Pubitemid 350020378)
30. Harty JI, Amin M, Wieman TJ, Tseng MT, Ackerman D, Broghamer W. 1989 Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J. Urol. 141, 1341-1346. (Pubitemid 19151791)
31. Jocham D, von WJ, Pfluger H, Steiner H, Doehn C, Buttner H, Bohle A, Kausch I. 2009 BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-A multicentre clinical phase III study. Aktuelle Urol. 40, 91-99. (doi:10.1055/s-0028-1098741)
32. Bader MJ et al. 2012 Photodynamic therapy of bladder cancer-A phase I study using hexaminolevulinate (HAL). Urol. Oncol. (doi:10.1016/j.urolonc.2012. 02.007)
33. Meyer M, Speight P, Bown SG. 1991 A study of the effects of photodynamic therapy on the normal tissues of the rabbit jaw. Br. J. Cancer 64, 1093-1097. (doi:10.1038/bjc.1991.470)
34. Campbell SM, Gould DJ, Salter L, Clifford T, Curnow A. 2004 Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan R-) for the treatment of vulval intraepithelial neoplasia. Br. J. Dermatol. 151, 1076-1080. (doi:10.1111/j.1365-2133.2004.06197.x) (Pubitemid 39573898)
35. Istomin YP, Lapzevich TP, Chalau VN, Shliakhtsin SV, Trukhachova TV. 2010 Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon. Photodiagnosis Photodyn. Ther. 7, 144-151. (doi:10.1016/j.pdpdt. 2010.06.005)
36. Kaiser PK et al. 2009 Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology 116, 747-755. (doi:10.1016/j.ophtha.2008.12.057)
37. Kharkwal GB, Sharma SK, Huang YY, Dai T, Hamblin MR. 2011 Photodynamic therapy for infections: clinical applications. Lasers Surg. Med. 43, 755-767.
38. Jenkins MP, Buonaccorsi GA, Raphael M, Nyamekye I, McEwan JR, Bown SG, Bishop CCR. 1999 Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br. J. Surg. 86, 1258-1263. (doi:10.1046/j.1365-2168.1999.01247.x) (Pubitemid 29481530)
39. Betz CS, Jager HR, Brookes JA, Richards R, Leunig A, Hopper C. 2007 Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region. Lasers Surg. Med. 39, 571-582. (doi:10.1002/lsm.20535) (Pubitemid 47502865)
40. Lou PJ, Lai PS, Shieh MJ, MacRobert AJ, Berg K, Bown SG. 2006 Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int. J. Cancer 119, 2692-2698. (doi:10.1002/ijc.22098) (Pubitemid 44696271)
41. Selbo PK, Weyergang A, Bonsted A, Bown SG, Berg K. 2006 Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells. J. Pharmacol. Exp. Ther. 319, 604-612. (doi:10.1124/jpet.106.109165)
42. Castano AP, Mroz P, Hamblin MR. 2006 Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6, 535-545. (doi:10.1038/nrc1894) (Pubitemid 43980542)
43. St Denis TG, Aziz K, Waheed AA, Huang YY, Sharma SK, Mroz P, Hambin MR. 2011 Combination approaches to potentiate immune response after photodynamic therapy for cancer. Photochem. Photobiol. Sci. 10, 792-801. (doi:10.1039/ c0pp00326c)
44. Korbelik M, Cooper PD. 2007 Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin. Br. J. Cancer 96, 67-72. (doi:10.1038/sj.bjc.6603508) (Pubitemid 46094641)
45. Theodossiou T, Hothersall JS, Woods EA, Okkenhaug K, Jacobson J, MacRobert AJ. 2003 Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. Cancer Res. 63, 1818-1821. (Pubitemid 36460843)